Ⅲ期非小细胞肺癌中非预期放疗再计划
本研究回顾性分析单中心2016年1月1日至2019年12月31日接受根治性放疗的144例新诊断Ⅲ期非小细胞肺癌患者,11%(n=16)在放疗开始后需再计划,原因均为锥形束CT发现靶区变化;较大的计划靶体积可预测再计划(OR 2.5,95%CI 1.2-5.4,P=.02);再计划与未再计划患者的总生存和局部复发相似。
要点
- 144例根治性放疗的Ⅲ期非小细胞肺癌患者中11%(n=16)发生非预期再计划。
- 再计划原因均为锥形束CT发现的靶区变化:移位10例、缩小5例、增大1例。
- 较大的计划靶体积(原发灶和淋巴结)可预测再计划(OR 2.5,95%CI 1.2-5.4,P=.02)。
核心结论
- 本研究中11%接受根治性放疗的非小细胞肺癌患者因锥形束CT发现的靶区变化需要再计划,较大的计划靶体积预测更高的自适应放疗需求,再计划与未再计划患者的总生存和局部控制相似。
研究设计与样本
- 单中心回顾性分析2016年1月1日至2019年12月31日接受根治性放疗的144例新诊断Ⅲ期非小细胞肺癌患者,采用逻辑回归分析再计划相关因素。
主要发现
- 144例患者中11%(n=16)在放疗开始后需要再计划,再计划原因为锥形束CT发现的靶区变化:移位10例、缩小5例、增大1例。
- 较大的计划靶体积(原发灶和淋巴结)可预测再计划(OR 2.5,95%CI 1.2-5.4,P=.02)。
- 16例再计划患者的中位总生存为33.3个月(95%CI 10.3-43.9),其余128例为36.3个月(95%CI 27.4-66.5),P=.96。
- 再计划患者的中位局部复发时间为25.0个月(95%CI 10.3-41.3),未再计划患者为19.5个月(95%CI 11.8-23.2),P=.28。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to identify factors associated with unanticipated radiation therapy (RT) replanning in stage III non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Patients from a single institution with newly diagnosed stage III NSCLC treated with radical RT from January 1, 2016, to December 31, 2019, were retrospectively analyzed. The frequency and reasons for replanning were determined. Logistic regression analysis was used to identify factors associated with replanning. RESULTS: Of 144 patients included in this study, 11% (n = 16) required replanning after the start of RT. The reason for replanning in these 16 patients was changes in the target detected by cone beam computed tomography (shift in 10 patients, shrinkage in 5 patients, and growth in 1 patient). Larger planning target volume (primary and nodal) was statistically predictive of replanning (odds ratio, 2.5; 95% CI, 1.2-5.4; P = .02). The actuarial median overall survival was 33.3 months (95% CI, 10.3-43.9) for the 16 patients who were replanned and 36.3 months (95% CI, 27.4-66.5) for the remaining 128 patients (P = .96). The median time to local recurrence was 25.0 months (95% CI, 10.3-41.3) for those patients who underwent replanning, which was similar to those patients who did not undergo replanning (19.5 months; 95% CI, 11.8-23.2; P = .28). CONCLUSIONS: In this study, 11% of patients treated with radical RT for NSCLC required replanning due to changes in the target detected by cone beam computed tomography. A larger planning target volume predicts a higher likelihood of requiring adaptive RT. Overall survival and local control were similar between patients who were replanned compared with those who were not replanned.
引用
- Mushonga M, Ung Y, Louie AV, et al. Unanticipated Radiation Replanning for Stage III Non-small Cell Lung Cancer. Adv Radiat Oncol. 2023. PMID: 38047222. doi:10.1016/j.adro.2023.101275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。